| Harry W Matelski, MD | |
|
206 Mill Rd, Fairhaven, MA 02719-5208 | |
| (508) 973-3000 | |
| (508) 973-3119 |
| Full Name | Harry W Matelski |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 47 Years |
| Location | 206 Mill Rd, Fairhaven, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699737874 | NPI | - | NPPES |
| 110066271A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 47369 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southcoast Hospitals Group | Fall river, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southcoast Physicians Group Inc | 0749171957 | 746 |
News Archive
In 2009, Minneapolis Heart Institute Foundation, along with Allina Health, New Ulm Medical Center and the community of New Ulm, Minnesota, began a 10-year population health research project to learn if heart attacks and heart disease risk factors within a community could be decreased through community efforts. Results for the first five years have been released, and the initial findings are positive.
A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.
Despite some efforts to ease the blow to pediatric health care providers, Texas' proposed budget cuts will most likely have a disproportionate effect on children's hospitals.
Cognoptix announced today that it has reached the halfway point in a multi-site clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes.
Molecular imaging aims at the visualization of molecules or molecular events that occur at the cellular level. Clearly it also allows the possibility of looking inside the biochemical pathway at the cellular level and therefore enables us to look at the onset of diseases well before they are resolved into structural change.
› Verified 4 days ago
| Entity Name | Southcoast Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336137629 PECOS PAC ID: 0749171957 Enrollment ID: O20040920000138 |
News Archive
In 2009, Minneapolis Heart Institute Foundation, along with Allina Health, New Ulm Medical Center and the community of New Ulm, Minnesota, began a 10-year population health research project to learn if heart attacks and heart disease risk factors within a community could be decreased through community efforts. Results for the first five years have been released, and the initial findings are positive.
A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.
Despite some efforts to ease the blow to pediatric health care providers, Texas' proposed budget cuts will most likely have a disproportionate effect on children's hospitals.
Cognoptix announced today that it has reached the halfway point in a multi-site clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes.
Molecular imaging aims at the visualization of molecules or molecular events that occur at the cellular level. Clearly it also allows the possibility of looking inside the biochemical pathway at the cellular level and therefore enables us to look at the onset of diseases well before they are resolved into structural change.
› Verified 4 days ago
| Entity Name | Southcoast Hospitals Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306871223 PECOS PAC ID: 1850282310 Enrollment ID: O20041214000621 |
News Archive
In 2009, Minneapolis Heart Institute Foundation, along with Allina Health, New Ulm Medical Center and the community of New Ulm, Minnesota, began a 10-year population health research project to learn if heart attacks and heart disease risk factors within a community could be decreased through community efforts. Results for the first five years have been released, and the initial findings are positive.
A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.
Despite some efforts to ease the blow to pediatric health care providers, Texas' proposed budget cuts will most likely have a disproportionate effect on children's hospitals.
Cognoptix announced today that it has reached the halfway point in a multi-site clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes.
Molecular imaging aims at the visualization of molecules or molecular events that occur at the cellular level. Clearly it also allows the possibility of looking inside the biochemical pathway at the cellular level and therefore enables us to look at the onset of diseases well before they are resolved into structural change.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Harry W Matelski, MD 200 Mill Rd, Ste 180, Fairhaven, MA 02719-5252 Ph: (508) 973-2000 | Harry W Matelski, MD 206 Mill Rd, Fairhaven, MA 02719-5208 Ph: (508) 973-3000 |
News Archive
In 2009, Minneapolis Heart Institute Foundation, along with Allina Health, New Ulm Medical Center and the community of New Ulm, Minnesota, began a 10-year population health research project to learn if heart attacks and heart disease risk factors within a community could be decreased through community efforts. Results for the first five years have been released, and the initial findings are positive.
A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.
Despite some efforts to ease the blow to pediatric health care providers, Texas' proposed budget cuts will most likely have a disproportionate effect on children's hospitals.
Cognoptix announced today that it has reached the halfway point in a multi-site clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes.
Molecular imaging aims at the visualization of molecules or molecular events that occur at the cellular level. Clearly it also allows the possibility of looking inside the biochemical pathway at the cellular level and therefore enables us to look at the onset of diseases well before they are resolved into structural change.
› Verified 4 days ago
Todd F Roberts, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 206 Mill Rd, Fairhaven, MA 02719 Phone: 508-973-3000 Fax: 508-973-3119 | |
Dr. Nicholas Robert Ondrasik, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-973-2224 Fax: 508-973-0394 | |
Dr. Alexis Pappas, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-973-2661 Fax: 508-973-0314 | |
Elizabeth M Blanchard, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 206 Mill Rd, Fairhaven, MA 02719 Phone: 508-973-3000 Fax: 508-973-3119 | |
Dr. Abena A. Addo, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-996-1800 Fax: 508-992-7906 | |
Chandra S Reddivari, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 200 Mill Road, Suite 190, Fairhaven, MA 02719 Phone: 508-973-0857 Fax: 508-973-2176 | |
Nosheen Javed, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-973-2207 Fax: 508-973-2505 |